SynDRA canonical compound SYN0026541 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · Rx/OTC |
| Primary target(s) | NR3C1 |
| Mechanism of action | anti-inflammatory agent | glucocorticoid receptor agonist |
| Indication | allergic rhinitis | anemia | asthma | bursitis | congenital adrenal hyperplasia | enteritis | epicondylitis | hypercalcemia | multiple sclerosis | osteoarthritis | psoriasis | rheumatoid arthritis | thyroiditis | ulcerative colitis |
| Disease area | allergy | dermatology | endocrinology | gastroenterology | hematology | infectious disease | neurology/psychiatry | pulmonary | rheumatology |